Oppenheimer Reiterates Outperform Rating on AngioDynamics (ANGO)
Tweet Send to a Friend
Oppenheimer analyst Steven M. Lichtman reiterated an Outperform rating and $13.00 price target on AngioDynamics (NASDAQ: ANGO).The analyst comments "ANGO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


